Literature DB >> 17066264

Gender discrepancies in the diagnosis of renal cortical tumors.

Phillip M Pierorazio1, Alana M Murphy, Mitchell C Benson, James M McKiernan.   

Abstract

Renal cell carcinoma (RCC) is more common in men than women although the relationship between sex and histologic sub-type of RCC is unknown. The Columbia University Urologic Oncology Database of 1,105 patients who underwent nephrectomy from 1990-2005 was reviewed. 1,018 patients were included who underwent renal surgery with complete demographic data and post-operative pathologic information; 49 with incomplete information and 36 with "granular" histology were excluded. Differences in histology, size and volume of primary tumor, laterality, chief complaint, age, pathologic stage and status were evaluated by sex using ANOVA techniques. The cohort included 671 (66.1%) men and 344 (33.8%) women. There were no differences in age (61.0 vs. 60.7 years, P = 0.36), size (6.22 vs. 5.53 cm, P = 0.08) or volume (305 vs. 129cc, P = 0.07) of primary tumor. Men were more likely to have bilateral tumors (9.6 vs. 3.5%, P = 0.003). A greater percentage of men had malignant pathologic histology at nephrectomy (90.9 vs. 84.0%, P = 0.002). The rate of malignancy for women increased from 44.5% for tumors < 1 cm to 92.7% for tumors greater than 10 cm; there was no trend noted in men. Women had a greater percentage of conventional RCC (77.2 vs. 70.5%, P = 0.04). When analyzed by histologic sub-type, men were more likely to have papillary histology than women (17.4 vs. 4.5%), women were more likely to have chromophobe histology (11.2 vs. 5.0%; P = 0.006). Differences in demographics, pathologic parameters and histologic sub-typing are observed between men and women treated for renal masses.

Entities:  

Mesh:

Year:  2007        PMID: 17066264     DOI: 10.1007/s00345-006-0124-9

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  7 in total

1.  Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases.

Authors:  Mahul B Amin; Mitual B Amin; Pheroze Tamboli; Javid Javidan; Hans Stricker; Mariza de-Peralta Venturina; Anita Deshpande; Mani Menon
Journal:  Am J Surg Pathol       Date:  2002-03       Impact factor: 6.394

2.  Comparison of laparoscopic partial nephrectomy and laparoscopic cryoablation for renal hilar tumors.

Authors:  Gregory Hruby; Karen Reisiger; Ramakrishna Venkatesh; Yan Yan; Jaime Landman
Journal:  Urology       Date:  2006-01       Impact factor: 2.649

3.  Obesity, hypertension, and the risk of kidney cancer in men.

Authors:  W H Chow; G Gridley; J F Fraumeni; B Järvholm
Journal:  N Engl J Med       Date:  2000-11-02       Impact factor: 91.245

4.  Papillary renal cell carcinoma: a clinical, radiologic, and pathologic study of 34 cases.

Authors:  R Mancilla-Jimenez; R J Stanley; R A Blath
Journal:  Cancer       Date:  1976-12       Impact factor: 6.860

5.  Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.

Authors:  Weber K Lau; John C Cheville; Michael L Blute; Amy L Weaver; Horst Zincke
Journal:  Urology       Date:  2002-04       Impact factor: 2.649

Review 6.  The Heidelberg classification of renal cell tumours.

Authors:  G Kovacs; M Akhtar; B J Beckwith; P Bugert; C S Cooper; B Delahunt; J N Eble; S Fleming; B Ljungberg; L J Medeiros; H Moch; V E Reuter; E Ritz; G Roos; D Schmidt; J R Srigley; S Störkel; E van den Berg; B Zbar
Journal:  J Pathol       Date:  1997-10       Impact factor: 7.996

7.  Solid renal tumors: an analysis of pathological features related to tumor size.

Authors:  Igor Frank; Michael L Blute; John C Cheville; Christine M Lohse; Amy L Weaver; Horst Zincke
Journal:  J Urol       Date:  2003-12       Impact factor: 7.450

  7 in total
  6 in total

1.  Decadal Experience of Renal Cell Carcinoma from a Tertiary Care Teaching Institute in North India.

Authors:  Singh Kawaljit; Sinha Rahul Janak; Gupta Ashok; Singh Vishwajeet
Journal:  Indian J Surg Oncol       Date:  2018-09-22

2.  Active surveillance for small renal masses.

Authors:  Phillip M Pierorazio; Elias S Hyams; Jeffrey K Mullins; Mohamad E Allaf
Journal:  Rev Urol       Date:  2012

3.  Preoperative predictors of malignancy and unfavorable pathology for clinical T1a tumors treated with partial nephrectomy: a multi-institutional analysis.

Authors:  Mark W Ball; Michael A Gorin; Sam B Bhayani; Craig G Rogers; Michael D Stifelman; Jihad H Kaouk; Homayoun Zargar; Susan Marshall; Jeffrey A Larson; Haider M Rahbar; Bruce J Trock; Phillip M Pierorazio; Mohamad E Allaf
Journal:  Urol Oncol       Date:  2014-12-11       Impact factor: 3.498

4.  Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma.

Authors:  Phillip M Pierorazio; Elias S Hyams; Salina Tsai; Zhaoyong Feng; Bruce J Trock; Jeffrey K Mullins; Pamela T Johnson; Elliot K Fishman; Mohamad E Allaf
Journal:  Urology       Date:  2013-04-17       Impact factor: 2.649

5.  Gender differences in clinicopathological features and survival in surgically treated patients with renal cell carcinoma: an analysis of the multicenter CORONA database.

Authors:  Matthias May; Atiqullah Aziz; Richard Zigeuner; Thomas Chromecki; Luca Cindolo; Luigi Schips; Ottavio De Cobelli; Bernardo Rocco; Cosimo De Nunzio; Andrea Tubaro; Ioman Coman; Michael Truss; Orietta Dalpiaz; Bernd Hoschke; Christian Gilfrich; Bogdan Feciche; Anette Stoltze; Fabian Fenske; Hans-Martin Fritsche; Robert S Figenshau; Kerry Madison; Manuel Sánchez-Chapado; Maria Del Carmen Santiago Martin; Luigi Salzano; Giuseppe Lotrecchiano; Steven Joniau; Raphaela Waidelich; Christian Stief; Sabine Brookman-May
Journal:  World J Urol       Date:  2013-04-09       Impact factor: 4.226

6.  Age-dependent association between sex and renal cell carcinoma mortality: a population-based analysis.

Authors:  Yuanyuan Qu; Haitao Chen; Weijie Gu; Chengyuan Gu; Hailiang Zhang; Jianfeng Xu; Yao Zhu; Dingwei Ye
Journal:  Sci Rep       Date:  2015-03-17       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.